Results from subgroup analyses of the Evaluate Renal Function with Semaglutide Once Weekly (FLOW), the Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity (SELECT), the Effect of Semaglutide 2.4 mg Once Weekly on Function and Symptoms in Subjects with Obesity-related Heart Failure with Preserved Ejection Fraction (STEP-HFpEF), and the Semaglutide Treatment Effect in People with Obesity and Heart Failure with Preserved Ejection Fraction and Diabetes Mellitus (STEP-HFpEF DM) trials showed that semaglutide tended to be more effective in younger patients, those with higher BMI, higher GFR, and lower HbA1c levels 22,23,24
For decades, researchers knew the gut signaled the pancreas to release insulin in response to food
Because your body does not make B12, you must get it through animal-based foods or from supplements
Silva specializes in evidence-based weight management and routinely manages GLP-1 therapy and related digestive side effects for patients at Potere Health MD in St
Compounded medications have not been evaluated or approved by the FDA for safety, efficacy, or quality
The gradual elimination over five weeks
